Pharmaceutical Companies
Laurus Generics Inc.
πΊπΈUnited States
- Ownership
- -
- Established
- -
- Employees
- -
- Market Cap
- $2.9B
- Website
- -
ImmunityBio
πΊπΈUnited States
- Ownership
- Public, Subsidiary
- Established
- 2014-01-01
- Employees
- 628
- Market Cap
- $2.9B
- Website
- http://www.immunitybio.com
ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the...
RHYTHM PHARMACEUTICALS, INC
πΈπͺSweden
- Ownership
- -
- Established
- -
- Employees
- -
- Market Cap
- $2.8B
- Website
- -
Piramal Pharma Inc.
πΊπΈUnited States
- Ownership
- -
- Established
- -
- Employees
- -
- Market Cap
- $2.8B
- Website
- -
Morphic Therapeutic, Inc.
πΊπΈUnited States
- Ownership
- Public, Subsidiary
- Established
- 2015-01-01
- Employees
- 101
- Market Cap
- $2.8B
- Website
- http://www.morphictx.com
MorphoSys
π©πͺGermany
- Ownership
- Public, Subsidiary
- Established
- 1992-01-01
- Employees
- 524
- Market Cap
- $2.8B
- Website
- http://www.morphosys.de
MorphoSys AG is a biopharmaceutical company dedicated to the discovery, development and commercialization of therapies for people living with cancer and autoimmune diseases. MorphoSys is advancing its own pipeline of new drug candidates...
Geron
πΊπΈUnited States
- Ownership
- -
- Established
- -
- Employees
- 141
- Market Cap
- $2.8B
- Website
- -
KOBAYASHI PHARMACEUTICALS
π―π΅Japan
- Ownership
- -
- Established
- -
- Employees
- -
- Market Cap
- $2.7B
- Website
- -
PTC Therapeutics
πΊπΈUnited States
PTC Therapeutics, Inc. is a biopharmaceutical company, which focuses on the discovery, development, and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. The company was founded...
Apogee Therapeutics
πΊπΈUnited States
- Ownership
- Public
- Established
- 2022-01-01
- Employees
- 91
- Market Cap
- $2.6B
Apogee Therapeutics, Inc. operates as a biotechnology company. It offers treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications. The company was founded...